Pharmacokinetics, pharmacodynamics, safety and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study
收藏DataCite Commons2024-02-08 更新2024-08-18 收录
下载链接：
https://figshare.com/articles/dataset/Pharmacokinetics_pharmacodynamics_safety_and_immunogenicity_of_Gerilimzumab_GB224_a_recombinant_humanized_interleukin-6_monoclonal_antibody_in_healthy_Chinese_adults_A_randomized_controlled_dose-escalation_study/22104764
下载链接
链接失效反馈官方服务：
资源简介：
https://www.tandfonline.com/doi/full/10.1080/13543784.2023.2178894
本数据集对应的学术资源可通过以下数字对象唯一标识符（Digital Object Identifier，DOI）链接获取：https://www.tandfonline.com/doi/full/10.1080/13543784.2023.2178894，该资源由Taylor & Francis出版集团发布。
提供机构：
figshare
创建时间：
2023-02-15
